[{"NetIncomeLoss_4_FY_USD":975040000.0,"EquityMethodInvestments_0_FY_USD":454936000.0,"FinancingReceivableAllowanceForCreditLosses_0_FY_USD":1263824000.0,"NetIncomeLossAttributableToNoncontrollingInterest_4_FY_USD":726914000.0,"GeneralAndAdministrativeExpense_4_FY_USD":181715000.0,"RepaymentsOfLongTermDebt_4_FY_USD":11116196000.0,"CommitmentsAndContingencies_0_FY_USD":null,"OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_4_FY_USD":60617000.0,"ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_4_FY_USD":12873000.0,"DerivativeLiabilitiesCurrent_0_FY_USD":0.0,"FinancingReceivableAllowanceForCreditLossesWriteOffs_4_FY_USD":25174000.0,"InterestPaidNet_4_FY_USD":103196000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_FY_USD":34395000.0,"NetCashProvidedByUsedInInvestingActivities_4_FY_USD":-2759320000.0,"StockIssuedDuringPeriodValueNewIssues_4_FY_USD":1908744000.0,"ProvisionForLoanLossesExpensed_4_FY_USD":156186000.0,"NotesAndLoansReceivableNetNoncurrent_0_FY_USD":12368084000.0,"AccountsPayableAndAccruedLiabilitiesCurrent_0_FY_USD":10775000.0,"DividendsCommonStockCash_4_FY_USD":112500000.0,"AssetsCurrent_0_FY_USD":2696898000.0,"IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_4_FY_shares":11000.0,"LongTermDebtCurrent_0_FY_USD":0.0,"ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_4_FY_USD":-6855000.0,"OtherNoncashIncomeExpense_4_FY_USD":-9621000.0,"PaymentsToAcquireAvailableForSaleSecuritiesDebt_4_FY_USD":0.0,"ProceedsFromIssuanceOfLongTermDebt_4_FY_USD":11891030000.0,"OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAfterAdjustmentsAndTax_4_FY_USD":4066000.0,"MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_4_FY_USD":1105765000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_4_FY_USD":83120000.0,"DueToRelatedPartiesCurrent_0_FY_USD":126366000.0,"Liabilities_0_FY_USD":6124471000.0,"OtherAssetsNoncurrent_0_FY_USD":23158000.0,"ResearchAndDevelopmentExpense_4_FY_USD":26289000.0,"FiniteLivedIntangibleAssetsAccumulatedAmortization_0_FY_USD":577550000.0,"EarningsPerShareBasic_4_FY_USD":1.32,"MinorityInterest_0_FY_USD":5077036000.0,"EquitySecuritiesFvNiUnrealizedGainLoss_4_FY_USD":247073000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_4_FY_shares":375455000.0,"GainsLossesOnExtinguishmentOfDebt_4_FY_USD":-30272000.0,"OtherNonoperatingIncomeExpense_4_FY_USD":-32821000.0,"IncomeTaxExpenseBenefit_4_FY_USD":0.0,"EquityMethodInvestmentDividendsOrDistributions_4_FY_USD":42334000.0,"Revenues_4_FY_USD":2122353000.0,"AvailableForSaleSecuritiesDebtSecuritiesNoncurrent_0_FY_USD":144416000.0,"InvestmentIncomeNet_4_FY_USD":28379000.0,"FinancingReceivableChangeInPresentValueExpenseReversal_4_FY_USD":-2964000.0,"IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_4_FY_USD":-766000.0,"InterestPayableCurrent_0_FY_USD":42146000.0,"IncreaseDecreaseInOtherCurrentAssets_4_FY_USD":10278000.0,"NetCashProvidedByUsedInFinancingActivities_4_FY_USD":1487172000.0,"CostsAndExpenses_4_FY_USD":526954000.0,"DerivativeAssetsNoncurrent_0_FY_USD":5439000.0,"NotesReceivableNet_0_FY_USD":12955277000.0,"ProceedsFromSaleAndMaturityOfMarketableSecurities_4_FY_USD":815440000.0,"IncreaseDecreaseInFinanceReceivables_4_FY_USD":1959975000.0,"OtherAssetsCurrent_0_FY_USD":8596000.0,"NetIncomeLossAvailableToCommonStockholdersBasic_4_FY_USD":495198000.0,"ComprehensiveIncomeNetOfTax_4_FY_USD":1028802000.0,"AmortizationOfIntangibleAssets_4_FY_USD":23058000.0,"CashAndCashEquivalentsAtCarryingValue_0_FY_USD":1008680000.0,"IncreaseDecreaseInOtherNoncurrentAssets_4_FY_USD":-45264000.0,"StockIssuedDuringPeriodValueShareBasedCompensation_4_FY_USD":5428000.0,"FairValueAssetLiabilityRecurringBasisStillHeldUnrealizedGainLoss_4_FY_USD":-45200000.0,"IncomeLossFromEquityMethodInvestments_4_FY_USD":44459000.0,"PaymentsToAcquireFinanceReceivables_4_FY_USD":2182246000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_0_FY_USD":89279000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_4_FY_USD":1701954000.0,"NetCashProvidedByUsedInOperatingActivities_4_FY_USD":2034629000.0,"ProceedsFromSaleOfAvailableForSaleSecuritiesDebt_4_FY_USD":3000000.0,"CommonStockDividendsPerShareCashPaid_4_FY_USD":0.15,"WeightedAverageNumberOfSharesOutstandingBasic_4_FY_shares":375444000.0,"DividendsCash_4_FY_USD":112490000.0,"TradingSecuritiesDebt_0_FY_USD":983279000.0,"OtherCostAndExpenseOperating_4_FY_USD":65053000.0,"LiabilitiesCurrent_0_FY_USD":307887000.0,"PaymentsOfDebtIssuanceCosts_4_FY_USD":46715000.0,"NonoperatingIncomeExpense_4_FY_USD":106555000.0,"InterestExpense_4_FY_USD":157059000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_FY_USD":1008680000.0,"IncreaseDecreaseInOtherReceivables_4_FY_USD":0.0,"LongTermDebtNoncurrent_0_FY_USD":5816584000.0,"NetIncomeLossAvailableToCommonStockholdersDiluted_4_FY_USD":495198000.0,"ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital_4_FY_USD":15084000.0,"AdditionalPaidInCapital_0_FY_USD":2865964000.0,"NotesAndLoansReceivableNetCurrent_0_FY_USD":587193000.0,"StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_0_FY_USD":9895815000.0,"FiniteLivedIntangibleAssetsNet_0_FY_USD":28666000.0,"NumberOfOperatingSegments_4_FY_segment":1.0,"ProvisionForLoanAndLeaseLosses_4_FY_USD":230839000.0,"DebtSecuritiesAvailableForSaleRealizedGain_4_FY_USD":0.0,"NotesReceivableGross_0_FY_USD":14219101000.0,"TreasuryStockValue_0_FY_USD":2317000.0,"PaymentsToAcquireEquityMethodInvestments_4_FY_USD":40155000.0,"EarningsPerShareDiluted_4_FY_USD":1.32,"GainLossOnDerivativeInstrumentsNetPretax_4_FY_USD":-42076000.0,"ProceedsFromInterestReceived_4_FY_USD":7704000.0,"AvailableForSaleSecuritiesDebtSecurities_0_FY_USD":214400000.0,"Assets_0_FY_USD":16020286000.0,"OtherComprehensiveIncomeLossNetOfTax_4_FY_USD":66635000.0,"StockholdersEquityOther_4_FY_USD":-191000.0,"ShareBasedCompensation_4_FY_USD":5428000.0,"OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax_4_FY_USD":20551000.0,"OperatingIncomeLoss_4_FY_USD":1595399000.0,"PaymentsForRepurchaseOfCommonStock_4_FY_USD":0.0,"AvailableForSaleSecuritiesDebtSecuritiesCurrent_0_FY_USD":69984000.0,"ProceedsFromIssuanceInitialPublicOffering_4_FY_USD":1908744000.0,"IncreaseDecreaseInInterestPayableNet_4_FY_USD":42146000.0,"FiniteLivedIntangibleAssetsGross_0_FY_USD":606216000.0,"LiabilitiesAndStockholdersEquity_0_FY_USD":16020286000.0,"AllocatedShareBasedCompensationExpense_4_FY_USD":5700000.0,"DerivativeLiabilitiesNoncurrent_0_FY_USD":0.0,"ProfitLoss_4_FY_USD":1701954000.0,"ProfitLoss_2_FY_USD":1077069000.0,"PaymentsToMinorityShareholders_4_FY_USD":543952000.0,"UnrealizedGainLossOnDerivatives_4_FY_USD":18600000.0,"AvailableForSaleDebtSecuritiesAmortizedCostBasis_0_FY_USD":125121000.0,"TransferOfInvestments_4_FY_USD":303679000.0,"AmortizationOfFinancingCostsAndDiscounts_4_FY_USD":11715000.0,"RetainedEarningsAccumulatedDeficit_0_FY_USD":1920635000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_4_FY_USD":762481000.0,"AssetImpairmentCharges_4_FY_USD":65053000.0,"PaymentsToAcquireMarketableSecurities_4_FY_USD":1705283000.0,"ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_4_FY_USD":1041675000.0,"Ticker":"RPRX","CIK":"1802768","name":"ROYALTY PHARMA PLC","OfficialName":"Royalty Pharma plc Class A Ordinary Shares ","form":"10-K","period":"20201231","fy":"2020.0","fp":"FY","qtrs":"4","uom":"USD","footnote":"nan","Market Cap":"19213987432.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20210224"}]